![Scott Huennekens](/system/files-encrypted/styles/large/encrypt/nasdaq_kms/people/2021/12/20/16-58-08/ScottHuennekens.jpeg?itok=GsVnqXVb)
Scott Huennekens
Chairman of the Board of Hyperfine
Scott has played a key role in more than 20 medtech start-up, growth, and public companies with market valuations totaling over $20 billion, that cumulatively have delivered therapeutics and diagnostics to more than 20 million patients. Mr. Huennekens has been named Ernst & Young Entrepreneur of the Year in 2010 and was recognized by Goldman Sachs in 2016, 2017, and 2018 as one of their 100 Most Intriguing Entrepreneurs.